Home > Healthcare > Medical Devices > Women Health Devices Market

Women Health Devices Market Analysis

  • Report ID: GMI3191
  • Published Date: Dec 2021
  • Report Format: PDF

Women Health Devices Market Analysis

Devices segment in the women health devices market is expected to showcase 6.7% growth rate through 2027. Increasing patient preference for technologically advanced treatment procedures coupled with upsurge of minimally invasive techniques has propelled demand for devices for several surgical procedures. Additionally, rising prevalence of chronic and infectious diseases among women would increase demand for better diagnosis and treatment options, thus contributing to the segment growth.

 

Contraceptives segment is estimated to attain a CAGR of 6.9% till 2027 led by the rising prevalence of sexually transmitted diseases among women. According to the WHO, every year around 374 million new infections occur, with one of four being sexually transmitted infections. In addition, growing inclination of population towards planned pregnancy increases demand for contraceptive implants, intrauterine devices (IUD) and systems this will fuel the segment expansion during the forecast period.

 

Osteoporosis segment captured more than USD 1 billion in 2020 impelled by the increasing prevalence of osteoporosis majorly among elderly population. Furthermore, osteoporosis is more common among females due to weaker bones. According to National Osteoporosis Foundation, around 10 million Americans have osteoporosis.

 

Ambulatory surgical centers held 14% of the market share in 2020. Various advantages associated with ambulatory surgical centers such as minimized risk of hospital-acquired infections (HAIs), shorter patient stay, cost-effective treatment and quality care will foster the segment demand. Additionally, accessibility to advanced technologies will further augment the segment value.

 

North America women health devices market accounted for over 32% of revenue share in 2020 owing to high awareness and adoption of women health devices including implants and self-diagnostic tests. Additionally, growing demand for technologically advanced solutions will accelerate the regional size. Moreover, government focus on maintaining women health & wellness, and presence of strong foothold of prominent industry leaders in the region will further stimulate the North America market progression over the coming years.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Market size of women health devices surpassed USD 26 billion in 2020 and will expand at a CAGR of over 6.9% from 2021 to 2027 driven by the surging awareness regarding women wellness and improving women care in remote areas.

The devices are anticipated to depict a growth rate of 6.7% up to 2027 owing to rising patient preference for technologically advanced treatment procedures and the upsurge of minimally invasive techniques.

The contraceptives will grow at a CAGR of 6.9% through 2027 considering the increasing prevalence of sexually transmitted diseases among women.

North America market recorded 32% of revenue share in 2020 and will grow with mounting awareness and adoption of numerous devices such as self-diagnostic tests and implants.

Major companies across the industry include F. Hoffman-La Roche, Caldera Medical, GE Healthcare, Carestream Health, CooperSurgical, Cardinal Health, and others.

Women Health Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2020
  • Companies covered: 13
  • Tables & Figures: 298
  • Countries covered: 23
  • Pages: 200
 Download Free Sample